PFIZER

New norms for MNC drug prices
New norms for MNC drug prices

In a move that would prevent MNCs such as GlaxoSmithKline (GSK), Eli Lilly, Roche and Pfizer from selling their drugs at a huge premium in India, the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes, arthritis, obesity, cancer and heart diseases.

European Consumers Seeking Health and Pharmaceutical Information
European Consumers Seeking Health and Pharmaceutical Information

Consumers in Europe are renowned for being extremely technologically advanced in terms of online activities and technology and device ownership. But due to the lack of direct-to-consumer advertising for pharmaceuticals, many pharmaceutical companies have assumed that consumers were somewhat passive participants in the patientphysician relationship.

whatsapp--v1 JOIN US
whatsapp--v1